Clinical Trials Directory

Trials / Conditions / Thyroid Associated Ophthalmopathies

Thyroid Associated Ophthalmopathies

9 registered clinical trials studyying Thyroid Associated Ophthalmopathies — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingEye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated
NCT07381413
Shanghai Changzheng Hospital—
RecruitingMHB018A Treatment in Patients With Active Thyroid Eye Disease
NCT06989918
Minghui Pharmaceutical (Hangzhou) LtdPhase 3
RecruitingEfficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TA
NCT07152366
Shanghai Changzheng HospitalPhase 4
RecruitingEvaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
NCT07152392
Shanghai Changzheng HospitalPhase 4
RecruitingThe Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to S
NCT07152340
Shanghai Changzheng HospitalPhase 4
WithdrawnSelenium in Mild Thyroid Eye Disease in North America
NCT02112643
Columbia UniversityPhase 3
CompletedTreatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analo
NCT02155049
Rabin Medical CenterPhase 3
CompletedTeprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease
NCT01868997
AmgenPhase 2
CompletedTocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
NCT01297699
Hospital Clinico Universitario de SantiagoPhase 3